Wellington Shields Capital Management, LLC Royalty Pharma PLC Transaction History

Wellington Shields Capital Management, LLC

$623 Million
Q3 2025

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$39.17 - $44.04 $1.93 Million - $2.17 Million	-49,166 Reduced 50.6%	48,007 $1.9 Million
Q2 2022 Aug 12, 2022	BUY	$37.53 - $44.22 $93,825 - $110,550	2,500 Added 2.64%	97,173 $4.09 Million
Q4 2021 Feb 15, 2022	BUY	$35.17 - $42.48 $106,635 - $128,799	3,032 Added 3.31%	94,673 $3.77 Million
Q3 2021 Nov 10, 2021	BUY	$36.14 - $42.24 $36 - $42	1 Added 0.0%	91,641 $3.31 Million
Q1 2021 May 12, 2021	SELL	$42.34 - $52.82 $84,680 - $105,640	-2,000 Reduced 2.14%	91,640 $4 Million

Q4 2020 Feb 09, 2021	BUY	$36.12 - $50.05 $3.38 Million - $4.69 Million	93,640 New	93,640 $4.69 Million

Others Institutions Holding RPRX

# of Institutions

540

Shares Held

303M

Call Options Held

1.34M

Put Options Held

252K

View Full List

About Royalty Pharma plc

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $17.1B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

More about RPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Shields Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Shields Capital Management, LLC with notifications on news.

Account